Answers are grounded in this paper and cite their sources.
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone secreted by L cells that regulates blood glucose levels by stimulating insulin secretion, regulating appetite, and β-cell growth. In this study, we screened eight 2-monoacylglycerols (2-MAGs) in STC-1 cells and identified 2-palmitoylglycerol (2-PG) as the most potent bioactive enhancer of GLP-1 secretion. Its activity was significantly greater than 2-oleoylglycerol (2-OG), which was previously reported to induce GLP-1 secretion. Pharmacological inhibition studies have indicated that GLP-1 secretion induced by 2-PG is attenuated by G protein-coupled receptor 119 (GPR119) and G protein-coupled receptor 40 (GPR40) antagonists. This is the first evidence indicating that GPR40 can be activated by 2-PG. Furthermore, to examine their physiological relevance, we evaluated the effect of two types of oils with similar fatty acid composition but different sn-2 fatty acid composition within triacylglycerols (TAGs) on GLP-1 secretion in mice. Mice administered oil enriched with palmitate at sn-2 exhibited significantly elevated total GLP-1 levels in portal vein 30 min after oil administration, compared to those administered oil enriched with oleate at sn-2 and palmitate at sn-1/sn-3. These findings suggest that both the specific fatty acid species of 2-MAGs and the positional distribution of fatty acids within TAGs critically influence GLP-1 secretion. This study highlights that 2-PG is a promising component for modulating GLP-1 secretion, which offers new insights into the development of nutritional therapeutic strategies for metabolic regulation.
No takes yet. Share an insight, caveat, or question.
Funatsu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: